Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

33%

2 trials in Phase 3/4

Results Transparency

0%

0 of 6 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4
2(100.0%)
2Total
Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT00297362Completed

A Study of the Safety and Effectiveness of Galantamine Hydrobromide in Patients With Alzheimer's Disease

Role: lead

NCT00297349Completed

A Study of the Safety of Topiramate Given in Combination With Other Medications in Adults and Children With Seizures

Role: lead

NCT00297336Completed

An Observational Study Evaluating the Safety of Topiramate for the Prevention of Migraine

Role: lead

NCT00297323Completed

An Observational Study of the Safety of Topiramate in Adults and Children With Epilepsy

Role: lead

NCT00216450Phase 4Completed

Study of the Safety and Effectiveness of Rabeprazole in Treatment of Helicobacter Pylori Infection in Adults.

Role: lead

NCT00216489Phase 4Completed

A Study of the Safety of Rabeprazole Administered to Adults With Gastroesophageal Reflux Disease (GERD)

Role: lead

All 6 trials loaded